Cidara Therapeutics earnings were -$183.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CDTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$23.5M, down 55.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CDTX reported annual earnings of -$169.8M, with 640.6% growth.
Cidara Therapeutics Earnings Reports & History FAQ
What were Cidara Therapeutics's earnings last quarter?
On CDTX's earnings call on Invalid Date, Cidara Therapeutics (NASDAQ: CDTX) reported Q1 2025 earnings per share (EPS) of -$1.66, up 27.19% year over year. Total CDTX earnings for the quarter were -$23.48 million. In the same quarter last year, Cidara Therapeutics's earnings per share (EPS) was -$2.28.
Is Cidara Therapeutics profitable or losing money?
As of the last Cidara Therapeutics earnings report, Cidara Therapeutics is currently losing money. Cidara Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$182.98 million, a 404.5% increase year over year.
What was CDTX's earnings growth in the past year?
As of Cidara Therapeutics's earnings date in Invalid Date, Cidara Therapeutics's earnings has grown year over year. CDTX earnings in the past year totalled -$182.98 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.